These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34445652)

  • 1. Thresholds of Endoglin Expression in Endothelial Cells Explains Vascular Etiology in Hereditary Hemorrhagic Telangiectasia Type 1.
    Galaris G; Montagne K; Thalgott JH; Goujon GJPE; van den Driesche S; Martin S; Mager HJ; Mummery CL; Rabelink TJ; Lebrin F
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary hemorrhagic telangiectasia, a vascular dysplasia affecting the TGF-beta signaling pathway.
    Fernández-L A; Sanz-Rodriguez F; Blanco FJ; Bernabéu C; Botella LM
    Clin Med Res; 2006 Mar; 4(1):66-78. PubMed ID: 16595794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of hereditary hemorrhagic telangiectasia type 1 in newborns by protein expression and mutation analysis of endoglin.
    Cymerman U; Vera S; Pece-Barbara N; Bourdeau A; White RI; Dunn J; Letarte M
    Pediatr Res; 2000 Jan; 47(1):24-35. PubMed ID: 10625079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral vascular abnormalities in a murine model of hereditary hemorrhagic telangiectasia.
    Satomi J; Mount RJ; Toporsian M; Paterson AD; Wallace MC; Harrison RV; Letarte M
    Stroke; 2003 Mar; 34(3):783-9. PubMed ID: 12624308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble endoglin regulates expression of angiogenesis-related proteins and induction of arteriovenous malformations in a mouse model of hereditary hemorrhagic telangiectasia.
    Gallardo-Vara E; Tual-Chalot S; Botella LM; Arthur HM; Bernabeu C
    Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30108051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoglin mutants retained in the endoplasmic reticulum exacerbate loss of function in hereditary hemorrhagic telangiectasia type 1 (HHT1) by exerting dominant negative effects on the wild type allele.
    Gariballa N; Badawi S; Ali BR
    Traffic; 2024 Jan; 25(1):e12928. PubMed ID: 38272447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia.
    Toporsian M; Gros R; Kabir MG; Vera S; Govindaraju K; Eidelman DH; Husain M; Letarte M
    Circ Res; 2005 Apr; 96(6):684-92. PubMed ID: 15718503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of modifier genes influencing transforming growth factor-beta1 levels in the development of vascular defects in endoglin heterozygous mice with hereditary hemorrhagic telangiectasia.
    Bourdeau A; Faughnan ME; McDonald ML; Paterson AD; Wanless IR; Letarte M
    Am J Pathol; 2001 Jun; 158(6):2011-20. PubMed ID: 11395379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development.
    Arthur HM; Ure J; Smith AJ; Renforth G; Wilson DI; Torsney E; Charlton R; Parums DV; Jowett T; Marchuk DA; Burn J; Diamond AG
    Dev Biol; 2000 Jan; 217(1):42-53. PubMed ID: 10625534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning of the promoter region of human endoglin, the target gene for hereditary hemorrhagic telangiectasia type 1.
    Ríus C; Smith JD; Almendro N; Langa C; Botella LM; Marchuk DA; Vary CP; Bernabéu C
    Blood; 1998 Dec; 92(12):4677-90. PubMed ID: 9845534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BMP Receptor Inhibition Enhances Tissue Repair in Endoglin Heterozygous Mice.
    Bakker W; Dingenouts CKE; Lodder K; Wiesmeijer KC; de Jong A; Kurakula K; Mager HJ; Smits AM; de Vries MR; Quax PHA; Goumans MJTH
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel brain arteriovenous malformation mouse models for type 1 hereditary hemorrhagic telangiectasia.
    Choi EJ; Chen W; Jun K; Arthur HM; Young WL; Su H
    PLoS One; 2014; 9(2):e88511. PubMed ID: 24520391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression analysis of four endoglin missense mutations suggests that haploinsufficiency is the predominant mechanism for hereditary hemorrhagic telangiectasia type 1.
    Pece-Barbara N; Cymerman U; Vera S; Marchuk DA; Letarte M
    Hum Mol Genet; 1999 Nov; 8(12):2171-81. PubMed ID: 10545596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor induces abnormal microvasculature in the endoglin heterozygous mouse brain.
    Xu B; Wu YQ; Huey M; Arthur HM; Marchuk DA; Hashimoto T; Young WL; Yang GY
    J Cereb Blood Flow Metab; 2004 Feb; 24(2):237-44. PubMed ID: 14747750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiopoietin-2 Inhibition Rescues Arteriovenous Malformation in a Smad4 Hereditary Hemorrhagic Telangiectasia Mouse Model.
    Crist AM; Zhou X; Garai J; Lee AR; Thoele J; Ullmer C; Klein C; Zabaleta J; Meadows SM
    Circulation; 2019 Apr; 139(17):2049-2063. PubMed ID: 30744395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced endothelial secretion and plasma levels of transforming growth factor-beta1 in patients with hereditary hemorrhagic telangiectasia type 1.
    Letarte M; McDonald ML; Li C; Kathirkamathamby K; Vera S; Pece-Barbara N; Kumar S
    Cardiovasc Res; 2005 Oct; 68(1):155-64. PubMed ID: 15907823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoglin has a crucial role in blood cell-mediated vascular repair.
    van Laake LW; van den Driesche S; Post S; Feijen A; Jansen MA; Driessens MH; Mager JJ; Snijder RJ; Westermann CJ; Doevendans PA; van Echteld CJ; ten Dijke P; Arthur HM; Goumans MJ; Lebrin F; Mummery CL
    Circulation; 2006 Nov; 114(21):2288-97. PubMed ID: 17088457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of Endothelial Endoglin Promotes High-Output Heart Failure Through Peripheral Arteriovenous Shunting Driven by VEGF Signaling.
    Tual-Chalot S; Garcia-Collado M; Redgrave RE; Singh E; Davison B; Park C; Lin H; Luli S; Jin Y; Wang Y; Lawrie A; Jakobsson L; Arthur HM
    Circ Res; 2020 Jan; 126(2):243-257. PubMed ID: 31805812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular defects associated with hereditary hemorrhagic telangiectasia revealed in patient-derived isogenic iPSCs in 3D vessels on chip.
    Orlova VV; Nahon DM; Cochrane A; Cao X; Freund C; van den Hil F; Westermann CJJ; Snijder RJ; Ploos van Amstel JK; Ten Dijke P; Lebrin F; Mager HJ; Mummery CL
    Stem Cell Reports; 2022 Jul; 17(7):1536-1545. PubMed ID: 35777360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative.
    Pece N; Vera S; Cymerman U; White RI; Wrana JL; Letarte M
    J Clin Invest; 1997 Nov; 100(10):2568-79. PubMed ID: 9366572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.